Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...

Evaluation of the combination of regorafenib + avelumab in patients with non-small cell lung cancer without oncogenic addiction: The phase II REGOMUNE study. This is an ASCO Meeting Abstract from the ...

Dana-Farber Cancer Institute investigators launch a first-of-its kind study to use a novel blood test to identify people who ...

The study found that cfDNA levels increase significantly ... and treatment response in cancers such as lung, breast, and colorectal cancer. Colorectal cancer is one of the most common cancers ...

Tens of thousands of patients with lung and breast cancer are to benefit from a “revolutionary” blood test on the NHS across England which can speed up access to targeted therapy. The new ‘liquid ...

Panelists discuss how to overcome barriers to comprehensive molecular testing and how to prioritize treatment when ALK+ ...

2 The new research, led by scientists at the German Cancer Research Center, compared diagnostic performance between the FDA-approved cfDNA blood test assessed in ECLIPSE and the FIT test used in ...

Prenatal cell-free DNA (cfDNA) screening during ... pancreatic, lung, kidney, bone, and adrenal gland cancers. Of the 52 with cancer, 29 (55.8 percent) had no symptoms of their disease.

Lung and bronchus cancer saw the biggest decline in deaths, falling by 4.5% each year in that four-year timeframe, according to the report. “This is largely due to early and more effective ...

Electronic nose breath analysis achieved 80-92% accuracy for detecting lung cancer in patients with suspicious findings. Detection accuracy remained consistent across tumor characteristics ...

Cell-free DNA (cfDNA) sequence analysis to screen for fetal aneuploidy can incidentally detect maternal cancer. Additional data are needed to identify DNA-sequencing patterns and other biomarkers ...